Chronic kidney disease stage is a modulator on the association between high-sensitivity c-reactive protein and coronary vasospastic angina

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Hsu, Heng Jung ^a,b   Yen, Chiung Hui ^c   Hsu, Kuang Hung ^d   Wu, I Wen ^a,b   Lee, Chin Chan ^a,b   Sun, Chiao Yin ^a,b   Chou, Chia Chi ^a,b   Chen, Chun Yu ^a,b   Yang, Shih Ying ^a,b   Tsai, Chi Jen ^a,b   Wu, Mai Szu ^a,b   Hung, Ming Jui ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATININE; HEMOGLOBIN; HIGH SENSITIVITY C REACTIVE PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY SPASM; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOCYTE; PROTEIN BLOOD LEVEL; AGED; ANGINA PECTORIS; CHRONIC KIDNEY FAILURE; CORONARY ARTERY DISEASE; METABOLISM; MULTIVARIATE ANALYSIS;

AGED; ANGINA PECTORIS; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; CORONARY VASOSPASM; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84898678255     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/852507     Document Type: Article

References (29)

1. Mann J. F. E., Gerstein H. C., Poque J., Bosch J., Yusuf S., Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Annals of Internal Medicine 2001 134 8 629 636 2-s2.0-0035901585
2. Go A. S., Chertow G. M., Fan D., McCulloch C. E., Hsu C.-Y., Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New England Journal of Medicine 2004 351 13 1296 1370 2-s2.0-4644221457 10.1056/NEJMoa041031
3. Schiffrin E. L., Lipman M. L., Mann J. F. E., Chronic kidney disease: effects on the cardiovascular system. Circulation 2007 116 1 85 97 2-s2.0-34347350171 10.1161/CIRCULATIONAHA.106.678342
4. Goodkin D. A., Bragg-Gresham J. L., Koenig K. G., Wolfe R. A., Akiba T., Andreucci V. E., Saito A., Rayner H. C., Kurokawa K., Port F. K., Held P. J., Young E. W., Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the dialysis outcomes and practice patterns study (dopps). Journal of the American Society of Nephrology 2003 14 12 3270 3277 2-s2.0-0344236397 10.1097/01.ASN.0000100127.54107.57
5. Foley R. N., Parfrey P. S., Sarnak M. J., Clinical epidemiology of cardiovascular disease in chronic renal disease. American Journal of Kidney Diseases 1998 32 5 S112 S119 2-s2.0-0031733696
6. Collins A. J., Kasiske B., Chen S.-C., Everson S., Constantini E., Grimm R., McBean M., Xue J., Chavers B., Matas A., Manning W., Louis T., Pan W., Liu J., Li S., Roberts T., Dalleska F., Snyder J., Ebben J., Frazier E., Sheets D., Johnson R., Li S., Dunning S., Berrini D., Guo H., Solid C., Arko C., Daniels F., Wang X., Forrest B., Gilbertson D., St Peter W., Frederick P., Eggers P., Agodoa L., Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. American Journal of Kidney Diseases 2003 42 6, supplement 5 A5 A7 2-s2.0-2942685965
7. Nishizawa S., Shiraishi J., Torii S., Miyagawa K., Arihara M., Hadase M., Hyogo M., Yagi T., Shima T., Kohno Y., Matsubara H., Intermediate fixed coronary artery stenosis at the site of ergonovine-provoked spasm as a predictor of long-term major adverse cardiac events of patients with coronary spastic angina. Circulation Journal 2009 73 4 699 704 2-s2.0-65649132657 10.1253/circj.CJ-08-0774
8. Bory M., Panagides D., Desfossez L., Coronary artery spasm in myocardial infarction. The Lancet 1993 342 8868 436 2-s2.0-0027236624
9. Romagnoli E., Lanza G. A., Acute myocardial infarction with normal coronary arteries: role of coronary artery spasm and arrhythmic complications. International Journal of Cardiology 2007 117 1 3 5 2-s2.0-33947122543 10.1016/j.ijcard.2006.10.001
10. Igarashi Y., Tamura Y., Suzuki K., Tanabe Y., Yamaguchi T., Fujita T., Yamazoe M., Aizawa Y., Shibata A., Coronary artery spasm is a major cause of sudden cardiac arrest in survivors without underlying heart disease. Coronary Artery Disease 1993 4 2 177 185 2-s2.0-0027394124
11. Hung M.-J., Cherng W.-J., Yang N.-I., Cheng C.-W., Li L.-F., Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease. American Journal of Cardiology 2005 96 11 1484 1490 2-s2.0-28044465431 10.1016/j.amjcard.2005.07.055
12. Hung M.-J., Cherng W.-J., Cheng C.-W., Li L.-F., Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease. American Journal of Cardiology 2006 97 10 1429 1434 2-s2.0-33646202185 10.1016/j.amjcard.2005.12.035
13. Itoh T., Mizuno Y., Harada E., Yoshimura M., Ogawa H., Yasue H., Coronary spasm is associated with chronic low-grade inflammation. Circulation Journal 2007 71 7 1074 1078 2-s2.0-34347242035 10.1253/circj.71.1074
14. Hung M.-J., Kuo L.-T., Cheng C.-W., Chang C.-P., Cherng W.-J., Comparison of peripheral monocyte counts in patients with and without coronary spasm and without fixed coronary narrowing. American Journal of Cardiology 2004 93 5 620 624 2-s2.0-1442348775 10.1016/j.amjcard.2003.11.033
15. Kato S., Chmielewski M., Honda H., Pecoits-Filho R., Matsuo S., Yuzawa Y., Tranaeus A., Stenvinkel P., Lindholm B., Aspects of immune dysfunction in end-stage renal disease. Clinical Journal of the American Society of Nephrology 2008 3 5 1526 1533 2-s2.0-53749090099 10.2215/CJN.00950208
16. Parikh N. I., Hwang S.-J., Larson M. G., Levy D., Fox C. S., Chronic kidney disease as a predictor of cardiovascular disease (from the framingham heart study). American Journal of Cardiology 2008 102 1 47 53 2-s2.0-46349111414 10.1016/j.amjcard.2008.02.095
17. Stevens L. A., Coresh J., Feldman H. I., Greene T., Lash J. P., Nelson R. G., Rahman M., Deysher A. E., Zhang Y., Schmid C. H., Levey A. S., Evaluation of the modification of diet in renal disease study equation in a large diverse population. Journal of the American Society of Nephrology 2007 18 10 2749 2757 2-s2.0-34948861586 10.1681/ASN.2007020199
18. Spruill W. J., Wade W. E., Cobb H. H. III, Estimating glomerular filtration rate with a modification of diet in renal disease equation: implications for pharmacy. American Journal of Health-System Pharmacy 2007 64 6 652 660 2-s2.0-33947577881 10.2146/ajhp060239
19. Hung M.-J., Cherng W.-J., Cheng C.-W., Yang N.-I., Effect of antispastic agents (calcium antagonists and/or isosorbide dinitrate) on high-sensitivity C-reactive protein in patients with coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease. American Journal of Cardiology 2005 95 1 84 87 2-s2.0-11144230981 10.1016/j.amjcard.2004.08.064
20. Koga S., Ikeda S., Nakata T., Yasunaga T., Takeno M., Koide Y., Maemura K., Low glomerular filtration rate is associated with high prevalence of vasospastic angina. Circulation Journal 2011 75 7 1691 1695 2-s2.0-79959764014 10.1253/circj.CJ-10-0864
21. Suzuki H., Kawai S., Aizawa T., Kato K., Sunayama S., Okada R., Yamaguchi H., Histological evaluation of coronary plaque in patients with variant angina: relationship between vasospasm and neointimal hyperplasia in primary coronary lesions. Journal of the American College of Cardiology 1999 33 1 198 205 2-s2.0-0032896815 10.1016/S0735-1097(98)00520-8
22. Marzilli M., Goldstein S., Trivella M. G., Some clinical considerations regarding the relation of coronary vasospasm to coronary atherosclerosis: a hypothetical pathogenesis. American Journal of Cardiology 1980 45 4 882 886 2-s2.0-0018835814
23. Ozaki Y., Keane D., Serruys P. W., Progression and regression of coronary stenosis in the long-term follow- up of vasospastic angina. Circulation 1995 92 9 2446 2456 2-s2.0-0028808547
24. Vanholder R., Glorieux G., Lameire N., New insights in uremic toxicity. Contributions to Nephrology 2005 149 315 324 2-s2.0-20544465914 10.1159/000085693
25. Vanholder R., de Smet R., Glorieux G., Argilés A., Baurmeister U., Brunet P., Clark W., Cohen G., De Deyn P. P., Deppisch R., Descamps-Latscha B., Henle T., Jörres A., Lemke H. D., Massy Z. A., Passlick-Deetjen J., Rodriguez M., Stegmayr B., Stenvinkel P., Tetta C., Wanner C., Zidek W., Review on uremic toxins: classification, concentration, and interindividual variability. Kidney International 2003 63 5 1934 1943 2-s2.0-0037406406 10.1046/j.1523-1755.2003.00924.x
26. Atoh K., Itoh H., Haneda M., Serum indoxyl sulfate levels in patients with diabetic nephropathy: relation to renal function. Diabetes Research and Clinical Practice 2009 83 2 220 226 2-s2.0-58249098422 10.1016/j.diabres.2008. 09.053
27. Raff A. C., Meyer T. W., Hostetter T. H., New insights into uremic toxicity. Current Opinion in Nephrology and Hypertension 2008 17 6 560 565 2-s2.0-56249108096 10.1097/MNH.0b013e32830f45b6
28. Ito T., Terashima M., Kaneda H., In vivo assessment of ergonovine-induced coronary artery spasm by 64-slice multislice computed tomography. Circulation 2012 5 226 232
29. Eddington H., Sinha S., Li E., Hegarty J., Ting J., Lane B., Chrysochou C., Foley R., O'Donoghue D., Kalra P. A., Middleton R., Factors associated with vascular stiffness: cross-sectional analysis from the chronic renal insufficiency standards implementation study. Nephron Clinical Practice 2009 112 3 c190 c198 2-s2.0-65549098272 10.1159/000218108